Seoul, July 31, 2024 – AtkinsRéalis Group Inc. (TSX: ATRL), a fully integrated professional services and project management company with offices around the world, has been awarded the design, engineering and procurement services contract by Kolon Global Corporation for a new Bioprocessing Production Center in Daejeon, South Korea. The project is owned by Merck, the leading science and technology company.
Planned on an area of 43,000 square meters, the bioprocessing manufacturing base is Merck’s Life Science business sector largest investment in the Asia-Pacific region, supporting the process development, clinical research and commercial manufacturing of biologic drugs. The Daejeon site will be equipped with advanced production facilities, a distribution center and an automated warehouse, marking Merck’s expansion in the region to support a growing and dynamic market. As part of the contract, AtkinsRéalis is providing process detail design and automation services, as well as procurement support for process equipment. To ensure meeting the highest level of accuracy and reliability, AtkinsRéalis will also deliver Quality Control (QC) lab analysis services for the project.
“In the world of pharmaceuticals and biotechnology, engineering, precision and innovation are key. We are pleased to work with Kolon Global Corporation and Merck and deliver a world-class facility that supports the advanced research, development and production of essential biotech products in South Korea,” said Wing Law, Chief Executive Officer, Asia, AtkinsRéalis. “Through our end-to-end services, industrial knowledge, and global capabilities, we’ll support the client with delivering this project to the highest quality and safety standards and making a significant contribution to critical drugs and public health.”
With a proven track record in delivering world-class projects in the industrial sector, AtkinsRéalis will utilize cGMP (Current Good Manufacturing Practice) as defined by the US FDA and EMA. Two recent successful projects include an API & Pharmaceutical products manufacturing facility by ST Pharm in Ansan, South Korea, and an API manufacturing facility for WuXi STA in Singapore, where AtkinsRéalis has been responsible for the design services, supporting regulatory compliance.
About AtkinsRéalis
Created by the integration of long-standing organizations dating back to 1911, AtkinsRéalis is a world-leading professional services and project management company dedicated to engineering a better future for our planet and its people. We create sustainable solutions that connect people, data and technology to transform the world's infrastructure and energy systems. We deploy global capabilities locally to our clients and deliver unique end-to-end services across the whole life cycle of an asset including consulting, advisory & environmental services, intelligent networks & cybersecurity, design & engineering, procurement, project & construction management, operations & maintenance, decommissioning and capital. The breadth and depth of our capabilities are delivered to clients in strategic sectors such as Engineering Services, Nuclear and Capital. News and information are available at www.atkinsrealis.com or follow us on LinkedIn.
Downloads
Trade releases